{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:48:06Z","timestamp":1794541686099,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11194-w","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:59:18Z","timestamp":1751363958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of inhaled ambroxol hydrochloride solution in patients with lower respiratory tract infectious diseases: a randomized, double-blind, placebo-controlled, multicentre clinical trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Di","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faguang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"4","key":"11194_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s00134-024-07381-z","volume":"50","author":"JIF Salluh","year":"2024","unstructured":"Salluh JIF, Povoa P, Beane A, Kalil A, Sendagire C, Sweeney DA, Pilcher D, Polverino E, Tacconelli E, Estenssoro E, Frat JP, Ramirez J, Reyes LF, Roca O, Nseir S, Nobre V, Lisboa T, Martin-Loeches I. Challenges for a broad international implementation of the current severe community-acquired pneumonia guidelines. Intensive Care Med. 2024;50(4):526\u201338. https:\/\/doi.org\/10.1007\/s00134-024-07381-z","journal-title":"Intensive Care Med"},{"key":"11194_CR2","unstructured":"Introduction to the. Database efficacy of different treatment modalities for lower respiratory tract infections in children. Pediatric Discovery Online."},{"issue":"2","key":"11194_CR3","doi-asserted-by":"publisher","first-page":"e13100","DOI":"10.1111\/irv.13100","volume":"17","author":"A Colosia","year":"2023","unstructured":"Colosia A, Costello J, McQuarrie K, Kato K, Bertzos K. Systematic literature review of the signs and symptoms of respiratory syncytial virus. Influenza Other Respir Viruses. 2023;17(2):e13100. https:\/\/doi.org\/10.1111\/irv.13100","journal-title":"Influenza Other Respir Viruses"},{"key":"11194_CR4","doi-asserted-by":"publisher","unstructured":"Franks LJ, Walsh JR, Hall K, Morris NR. Measuring airway clearance outcomes in bronchiectasis: a review. Eur Respir Rev. 2020;29(156). https:\/\/doi.org\/10.1183\/16000617.0161-2019","DOI":"10.1183\/16000617.0161-2019"},{"issue":"10","key":"11194_CR5","doi-asserted-by":"publisher","first-page":"e46866","DOI":"10.7759\/cureus.46866","volume":"15","author":"G Singh","year":"2023","unstructured":"Singh G, Acharya S, Shukla S, Jain D. Muco-Obstructive lung disease: A systematic review. Cureus. 2023;15(10):e46866. https:\/\/doi.org\/10.7759\/cureus.46866","journal-title":"Cureus"},{"key":"11194_CR6","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.2147\/COPD.S381131","volume":"17","author":"F Patalano","year":"2022","unstructured":"Patalano F, Hache C, Pethe A, Kaur H, Leidy NK, Arsiwala T, Afroz N, Gutzwiller FS. Performance of the cough and sputum assessment questionnaire (CASA-Q) in COPD: evidence from clinical and online patient interaction studies. Int J Chron Obstruct Pulmon Dis. 2022;17:3087\u201396. https:\/\/doi.org\/10.2147\/COPD.S381131","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"8","key":"11194_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1517\/17425255.4.8.1119","volume":"4","author":"M Malerba","year":"2008","unstructured":"Malerba M, Ragnoli B. Ambroxol in the 21st century: Pharmacological and clinical update. Expert Opin Drug Metab Toxicol. 2008;4(8):1119\u201329. https:\/\/doi.org\/10.1517\/17425255.4.8.1119","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"9","key":"11194_CR8","first-page":"1176","volume":"52","author":"DF Rogers","year":"2007","unstructured":"Rogers DF. Mucoactive agents for airway mucus hypersecretory diseases. Respir Care. 2007;52(9):1176\u201393. discussion 1193\u2013\u20091177.","journal-title":"Respir Care"},{"issue":"2","key":"11194_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.hrtlng.2018.09.010","volume":"48","author":"BJ Tarrant","year":"2019","unstructured":"Tarrant BJ, Maitre CL, Romero L, Steward R, Button BM, Thompson BR, Holland AE. Mucoactive agents for adults with acute lung conditions: A systematic review. Heart Lung. 2019;48(2):141\u20137. https:\/\/doi.org\/10.1016\/j.hrtlng.2018.09.010","journal-title":"Heart Lung"},{"issue":"11","key":"11194_CR10","doi-asserted-by":"publisher","first-page":"e21105","DOI":"10.1016\/j.heliyon.2023.e21105","volume":"9","author":"H Shen","year":"2023","unstructured":"Shen H, Zhao X, Xu L. Meta-analysis of the efficacy of Budesonide and ambroxol hydrochloride inhalation in children with pneumonia and their effects on inflammatory response. Heliyon. 2023;9(11):e21105. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21105","journal-title":"Heliyon"},{"issue":"5","key":"11194_CR11","first-page":"5019","volume":"13","author":"F Yu","year":"2021","unstructured":"Yu F, Li C, Liu M, Shen T, Liu C. Aerosol inhalation of ambroxol hydrochloride combined with Terbutaline can promote recovery of children with severe pneumonia. Am J Transl Res. 2021;13(5):5019\u201326.","journal-title":"Am J Transl Res"},{"issue":"10","key":"11194_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1691\/ph.2017.7541","volume":"72","author":"Z Yang","year":"2017","unstructured":"Yang Z, Xiao X, Huang Y, He X, Lu Q, Chen S, Lin Z. Effects and mechanisms of ambroxol inhalation (Mucosolvan((R))) in the treatment of neonatal pneumonia. Pharmazie. 2017;72(10):604\u20137. https:\/\/doi.org\/10.1691\/ph.2017.7541","journal-title":"Pharmazie"},{"key":"11194_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejphar.2016.02.030","volume":"775","author":"SJ Zhang","year":"2016","unstructured":"Zhang SJ, Jiang JX, Ren QQ, Jia YL, Shen J, Shen HJ, Lin XX, Lu H, Xie QM. Ambroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1\/2 signaling pathway. Eur J Pharmacol. 2016;775:138\u201348. https:\/\/doi.org\/10.1016\/j.ejphar.2016.02.030","journal-title":"Eur J Pharmacol"},{"key":"11194_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.intimp.2016.02.004","volume":"33","author":"LT Ge","year":"2016","unstructured":"Ge LT, Liu YN, Lin XX, Shen HJ, Jia YL, Dong XW, Sun Y, Xie QM. Inhalation of ambroxol inhibits cigarette smoke-induced acute lung injury in a mouse model by inhibiting the Erk pathway. Int Immunopharmacol. 2016;33:90\u20138. https:\/\/doi.org\/10.1016\/j.intimp.2016.02.004","journal-title":"Int Immunopharmacol"},{"key":"11194_CR15","doi-asserted-by":"publisher","first-page":"1182602","DOI":"10.3389\/fmed.2023.1182602","volume":"10","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Yang K, Liu N, Fu X, He H, Chen H, Xu P, Wang J, Liu M, Tang Y, Zhao F, Xu S, Yu X, Han J, Yuan B, Jia B, Pang G, Shi Y, Kuang M, Shao H, Xiong H, He J, Pan Y, Chen R. Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficulty. Front Med (Lausanne). 2023;10:1182602. https:\/\/doi.org\/10.3389\/fmed.2023.1182602","journal-title":"Front Med (Lausanne)"},{"key":"11194_CR16","doi-asserted-by":"publisher","unstructured":"Sypalov SA, Varsegov IS, Ulyanovskii NV, Lebedev AT, Kosyakov DS. Mucolytic drugs ambroxol and bromhexine: transformation under aqueous chlorination conditions. Int J Mol Sci. 2024;25(10). https:\/\/doi.org\/10.3390\/ijms25105214","DOI":"10.3390\/ijms25105214"},{"issue":"11","key":"11194_CR17","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1517\/17460441.2011.629646","volume":"6","author":"D Paleari","year":"2011","unstructured":"Paleari D, Rossi GA, Nicolini G, Olivieri D. Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood. Expert Opin Drug Discov. 2011;6(11):1203\u201314. https:\/\/doi.org\/10.1517\/17460441.2011.629646","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"11194_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1172\/JCI119138","volume":"99","author":"PJ Wills","year":"1997","unstructured":"Wills PJ, Hall RL, Chan W, Cole PJ. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J Clin Invest. 1997;99(1):9\u201313. https:\/\/doi.org\/10.1172\/JCI119138","journal-title":"J Clin Invest"},{"key":"11194_CR19","doi-asserted-by":"publisher","first-page":"1335058","DOI":"10.3389\/fphar.2024.1335058","volume":"15","author":"FE Mohamed","year":"2024","unstructured":"Mohamed FE, Al-Jasmi F. Exploring the efficacy and safety of ambroxol in gaucher disease: an overview of clinical studies. Front Pharmacol. 2024;15:1335058. https:\/\/doi.org\/10.3389\/fphar.2024.1335058","journal-title":"Front Pharmacol"},{"issue":"3","key":"11194_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.21037\/atm-22-237","volume":"10","author":"X Zhou","year":"2022","unstructured":"Zhou X, Jin X, Yang L, Wei X. Efficacy and safety of ambroxol hydrochloride in the treatment of secretory otitis media: a systematic review and meta-analysis. Annals Translational Med. 2022;10(3):142. https:\/\/doi.org\/10.21037\/atm-22-237","journal-title":"Annals Translational Med"},{"issue":"4","key":"11194_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4046\/trd.2022.0074","volume":"85","author":"YS Jo","year":"2022","unstructured":"Jo YS. Long-Term outcome of chronic obstructive pulmonary disease: A review. Tuberc Respir Dis (Seoul). 2022;85(4):289\u2013301. https:\/\/doi.org\/10.4046\/trd.2022.0074","journal-title":"Tuberc Respir Dis (Seoul)"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11194-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11194-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11194-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:59:19Z","timestamp":1751363959000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11194-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11194"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11194-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients signed the informed consent. The Ethics Committee of Peking University People\u2019s Hospital approved the trial with the Ethics number of 2013-21. The trial was registered on Chinese Clinical Trial Registry with the number of ChiCTR2300072467.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"830"}}